Abstract
to develop and validate a scale for assessing the quality of life of women with Human Papillomavirus infection. a methodological study to develop the stages of item elaboration, apparent and content validation, semantic validation, pre-test, item allocation in domains, and reliability. 98 items were elaborated and submitted to apparent and content validation (version 2; n=05). In semantic validation, 90.9% of women considered all items clear and understandable (version 3; n=11). In pre-test, the best applicability was in the form of a self-administered questionnaire in relation to the interview (version 4; n=38). The Exploratory Factor Analysis allocated 58 items in 6 domains; (version 5; n=351). For reliability, the general Cronbach's alpha value was 0.883. the instrument proved to be valid and reliable for assessing the quality of life of women with Human Papillomavirus infection, consisting of 54 items allocated in 6 domains.
Highlights
Human Papillomaviruses (HPV) is a group that aggregates more than 200 virus subtypes, in which each subtype of this large group is called a number
In Brazil, in 2018, it was estimated that 54.6% of young people aged between 16 and 25 years were infected with HPV
This study presented the process of preparing and validating EQUALI-HPV
Summary
Human Papillomaviruses (HPV) is a group that aggregates more than 200 virus subtypes, in which each subtype of this large group is called a number. 13 types are considered oncogenic, offering a higher probability or risk of causing persistent infections and precursor lesions. According to the Information Center on HPV and Cervical Cancer (ICO), in 2019, there were 5,880,000 people infected with HPV worldwide. 2,784,000 were women over 15 years of age, among whom cervical cancer emerges as the fourth most frequent type of cancer[3]. In Brazil, in 2018, it was estimated that 54.6% of young people aged between 16 and 25 years were infected with HPV. In 2020, 16,590 new cases of cervical cancer should appear, which corresponds to 16.59 cases per 100 thousand women[1,4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
